Published in Antimicrob Agents Chemother on September 01, 1978
Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli. Antimicrob Agents Chemother (1982) 1.03
Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae. Antimicrob Agents Chemother (1983) 0.97
Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother (1982) 0.96
Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin. Antimicrob Agents Chemother (1983) 0.94
Antibiotic adjuvants: identification and clinical use. Microb Biotechnol (2013) 0.89
Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi. Antimicrob Agents Chemother (1980) 0.88
Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas. Antimicrob Agents Chemother (1980) 0.85
Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease. Antimicrob Agents Chemother (1992) 0.81
Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates. Antimicrob Agents Chemother (1982) 0.75
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother (1978) 7.39
In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. Antimicrob Agents Chemother (1977) 7.35
In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother (1978) 4.29
Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin. J Antibiot (Tokyo) (1977) 2.01
Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics. Antimicrob Agents Chemother (1978) 1.81
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother (1989) 7.92
Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc (1975) 7.01
Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteria. J Clin Microbiol (1991) 4.91
Evaluation of routine subcultures of macroscopically negative blood cultures for detection of anaerobes. J Clin Microbiol (1978) 3.96
Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole. Antimicrob Agents Chemother (1978) 3.29
Clinical laboratory comparison of a slide blood culture system with a conventional broth system. J Clin Microbiol (1982) 2.95
Mycobacterial cross contamination during radiometric culturing. J Clin Microbiol (1988) 2.56
Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia. J Clin Microbiol (1997) 2.54
Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol (1994) 2.44
Effects of selective media and atmosphere of incubation on the isolation of group A streptococci. J Clin Microbiol (1976) 2.38
Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus. Antimicrob Agents Chemother (1977) 2.35
Standardization of the Analytab Enteric (API 20E) system to increase accuracy and reproducibility of the test for biotype characterization of bacteria. J Clin Microbiol (1978) 2.11
In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeae. Antimicrob Agents Chemother (1979) 2.09
Mycobacterial cross-contamination with the modified BACTEC 460 TB System. Diagn Microbiol Infect Dis (1991) 2.00
Comparison of anaerobic susceptibility results obtained by different methods. Antimicrob Agents Chemother (1979) 1.96
Detection of bacteriuria: manual screening test and early examination of agar plates. J Clin Microbiol (1981) 1.94
The accuracy of diagnosing pulmonary tuberculosis at a teaching hospital. Am Rev Respir Dis (1980) 1.92
Comparative evaluation of three identification systems for anaerobes. J Clin Microbiol (1985) 1.90
Clinical laboratory evaluation of a urine screening device. J Clin Microbiol (1983) 1.83
Clinical evaluation of three urine screening tests. J Clin Microbiol (1987) 1.81
Evaluation of the Quantum II and Rapid E identification systems. J Clin Microbiol (1984) 1.76
Reproducibility problems with the Abbott laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2000) 1.70
Quantitative susceptibility test methods in major United States medical centers. Antimicrob Agents Chemother (1981) 1.70
Effect of calcium on in vitro activity of LY146032 against Clostridium difficile. Antimicrob Agents Chemother (1987) 1.68
Inactivation of penicillins by Thiol broth. J Clin Microbiol (1982) 1.59
Reliability of disc diffusion susceptibility testing. Infect Control (1982) 1.57
Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin. J Clin Microbiol (1991) 1.55
Paecilomyces variotii contamination in the lumen of a saline-filled breast implant. Plast Reconstr Surg (1995) 1.54
Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium. Diagn Microbiol Infect Dis (1992) 1.53
Source of elastin-degrading enzymes in mycotic aortic aneurysms: bacteria or host inflammatory response? Cardiovasc Surg (1999) 1.53
Modification of the bile solubility test for rapid identification of Streptococcus pneumoniae. J Clin Microbiol (1979) 1.52
The acid-fast stain: a specific and predictive test for mycobacterial disease. Ann Intern Med (1980) 1.51
A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination. Am J Med (1999) 1.41
Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. Am Rev Respir Dis (1992) 1.33
Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay. J Clin Microbiol (1984) 1.33
Sodium polyanethol sulfonate inactivation of aminoglycosides. Antimicrob Agents Chemother (1981) 1.32
Growth of clinical isolates of anaerobic bacteria on agar media: effects of media composition, storage conditions, and reduction under anaerobic conditions. J Clin Microbiol (1978) 1.31
Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis (1990) 1.29
In vitro antibacterial activity of cefpiramide. Antimicrob Agents Chemother (1984) 1.28
Identification of clinical isolates of anaerobic bacteria using matrix-assisted laser desorption ionization-time of flight mass spectrometry. Eur J Clin Microbiol Infect Dis (2012) 1.25
Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species. Eur J Clin Microbiol Infect Dis (2008) 1.21
Bacitracin differentiation for presumptive identification of group A beta-hemolytic streptococci: comparison of primary and purified plate testing. J Pediatr (1976) 1.20
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
Identification of bacteria recovered from clinical specimens by 16S rRNA gene sequencing. Eur J Clin Microbiol Infect Dis (2003) 1.20
Susceptibility testing with anaerobic blood culture isolates. Comparison of a rapid, direct methods with standardized method. Am J Clin Pathol (1980) 1.19
Bacterial interference by oropharynegeal and clinical isolates of anaerobic bacteria. J Infect Dis (1976) 1.15
Evaluation of the Kirby-Bauer disc diffusion test as a screening test for high-level aminoglycoside resistance in enterococci. Am J Clin Pathol (1984) 1.14
Should yeasts in respiratory secretions be identified? Mayo Clin Proc (1977) 1.14
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates. J Antimicrob Chemother (1993) 1.13
Evaluation of microparticle enzyme immunoassays for immunoglobulins G and M to rubella virus and Toxoplasma gondii on the Abbott IMx automated analyzer. J Clin Microbiol (1989) 1.12
Antimicrobial susceptibility patterns of Haemophilus isolates from children in eleven developing nations. BOSTID Haemophilus Susceptibility Study Group. Bull World Health Organ (1990) 1.12
Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan. J Clin Microbiol (1991) 1.11
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae. Diagn Microbiol Infect Dis (1991) 1.10
Genotypic analysis of invasive Streptococcus pneumoniae from Mali, Africa, by semiautomated repetitive-element PCR and pulsed-field gel electrophoresis. J Clin Microbiol (2006) 1.10
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain. J Clin Microbiol (1992) 1.07
Adaptation of an automated microbiology system for the growth of anaerobes and performance of antimicrobial susceptibility tests. Am J Clin Pathol (1982) 1.06
Induction of type C viruses in cultured guinea pig cells. J Virol (1973) 1.05
Value of routine aerobic subculturing of unvented blood culture bottles. J Clin Microbiol (1983) 1.05
Determination of the optimum incubation period of blood culture broths for the detection of clinically significant septicemia. J Clin Microbiol (1985) 1.04
Rapid presumptive identification of anaerobes in blood cultures by gas-liquid chromatography. J Clin Microbiol (1980) 0.99
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers. Eur J Epidemiol (1993) 0.99
Current controversies in the detection of septicemia. Eur J Clin Microbiol (1986) 0.99
Relative recovery of anaerobes on different isolation media. J Clin Microbiol (1979) 0.98
Inoculum preparation for anaerobic susceptibility tests. J Clin Microbiol (1983) 0.98
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelines. Diagn Microbiol Infect Dis (1992) 0.97
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin. J Clin Microbiol (1992) 0.94
Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin. J Clin Microbiol (1992) 0.94
Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci. J Clin Microbiol (1998) 0.93
Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol (1996) 0.93
Recovery of group A and nongroup A beta-hemolytic streptococci from throat swab specimens. Mayo Clin Proc (1977) 0.93
Effect of filtration on antimicrobial solutions. Antimicrob Agents Chemother (1981) 0.92
Contemporary testing for enteric pathogens: the potential for cost, time, and health care savings. J Clin Microbiol (1996) 0.92
Characterization of bromodeoxyuridine-induced endogenous guinea pig virus. J Virol (1974) 0.91
Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae. J Clin Microbiol (1992) 0.91
Recovery of pathogenic bacteria from cerebrospinal fluid. J Clin Microbiol (1980) 0.90
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis (1994) 0.89
Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime. Antimicrob Agents Chemother (1993) 0.89
In vivo selection of resistance to multiple cephalosporins by enterobacter cloacae. J Infect Dis (1983) 0.88
Comparative study of the ability of four aminoglycoside assay techniques to detect the inactivation of aminoglycosides by beta-lactam antibiotics. Diagn Microbiol Infect Dis (1984) 0.88
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines. Diagn Microbiol Infect Dis (1992) 0.87
Antimicrobial efficacy and corneal endothelial toxicity of DexSol corneal storage medium supplemented with vancomycin. Ophthalmology (1991) 0.87
Prevalence of Corynebacterium urealyticum in urine specimens collected at a university-affiliated medical center. J Clin Microbiol (1994) 0.86
Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas. Antimicrob Agents Chemother (1980) 0.85
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin. J Clin Microbiol (1992) 0.85
Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: a multilaboratory collaborative evaluation. J Clin Microbiol (1996) 0.85
Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products. Cytotherapy (2004) 0.84
Anaerobic susceptibility tests. Evaluation of the stability of antimicrobials in Wilkens-Chalgren broth and the effect of media prereduction. J Antibiot (Tokyo) (1978) 0.83
The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients. Bone Marrow Transplant (2007) 0.82
Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116)). J Antimicrob Chemother (1996) 0.81
Evaluation of Mueller-Hinton agar for disk diffusion susceptibility tests. J Clin Microbiol (1983) 0.80
Heparin interferes with the radioenzymatic and homogeneous enzyme immunoassays for aminoglycosides. Clin Chem (1982) 0.80
Comparison of tryptic soy broth with tryptic soy broth supplemented with sucrose in the septi-chek blood culture system. J Clin Microbiol (1983) 0.79
Improved diagnostic accuracy using monoclonal antibody group A streptococcal carbohydrate. J Clin Microbiol (1980) 0.79
Corneal endothelial toxicity of DexSol corneal storage medium supplemented with povidone-iodine. Arch Ophthalmol (1992) 0.78
Manual approaches to rapid microbiology results. Diagn Microbiol Infect Dis (1985) 0.78
Detection of Clostridium difficile cytotoxin in HEp-2 and CHO cell lines. Diagn Microbiol Infect Dis (1983) 0.78
Microdilution and agar replica identification test systems. Clin Lab Med (1985) 0.77
Microbial growth inside saline-filled breast implants. Plast Reconstr Surg (1997) 0.77
Comparison of the Vitek Immunodiagnostic Assay System with three immunoassay systems for detection of cytomegalovirus-specific immunoglobulin G. J Clin Microbiol (1992) 0.77
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates. Antimicrob Agents Chemother (1991) 0.76